BridgeMD
New treatment option for Cancer
Official title Psychological Factors Influencing Cancer Post-traumatic Growth
ClinicalTrials.gov ID: NCT06278558
What this study is testing
- What it's testing
- The study focuses on post-traumatic growth (positive changes linked to appreciation of life, personal strengths, social relationships...) in the context of different types of cancer and with a longitudinal approach to the care pathway. The aim of the study is to better understand whether psychological variables (emotional competence, psychological flexibility, psychological distress) and patients' care satisfaction, assessed at the start of the cancer treatment pathway, can influence their post-traumatic growth at the end of the chemotherapy protocol and 6 months later.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients over 18 years of age
- Patients in the initial phase of curative treatment for a 1st solid cancer
- At the start of neo-adjuvant or adjuvant chemotherapy (1st course or 2nd course)
- At less than 6 months from the initial diagnosis
- Patient having given written consent to participate in the study
You likely can't join if
- Patients with a previous history of cancer
- Patients with incurable cancer progression, recurrence or relapse
- Metastatic, brain, hematological or skin cancer
- Patients who have difficulty understanding written French
- Patient psychologically or physically unable to answer questionnaires
The study team makes the final eligibility decision.
Where it's taking place
- Valenciennes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Valenciennes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.